As Supreme Court Mulls Overtime for Pharma Sales Reps, Novartis Settles Class Action for $99 Million


If the Supreme Court rules later this year that pharmaceutical sales representatives are exempt from overtime requirements of the Fair Labor Standards Act, the high court could knock out class action wage-and-hour claims pending against a half-dozen major drug companies. But Novartis and its lawyers at Cravath apparently weren't willing to gamble that the Justices would see things the drug companies' way.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisAdvance® Here

Not a LexisAdvance® Subscriber?

Subscribe Now

Why am I seeing this?

LexisAdvance® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisAdvance® customers will be able to access and use ALM's content by subscribing to the LexisAdvance® services via® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Legaltech News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisAdvance® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202540012388

Thank you!

This article's comments will be reviewed.